Candida albicans particles

PN solutions should be administered with an infusion pump to ensure consistent and controlled delivery of the solution. The intravenous administration line may include an in-line filter at a point prior to connection to the catheter. A 0.22-micron filter is recommended for use with CAA-dextrose solutions to remove particulate matter, air, and any microorganisms that may be present in the solution from prior manipulations of the admixture or the administration line. Because the average size of IVLE particles is approximately 0.5 micron, IVLEs administered separately from the CAA-dextrose solution must be piggybacked into the PN line at a site beyond the in-line fllter. Routine use of in-line filters (>0.22 micron) with TNA solutions is controversial. However, the FDA recommends use of a 1.2-micron filter, which may be effective in preventing catheter occlusion due to precipitates or lipid aggregates. This filter size is also reported to remove Candida albicans. 

---